Comparison the effect of melatonin and the selective inhibitor of serotonin reuptake citalopram drug on the ultrastructure of liver tissue and hepatic enzymes in Adult Female three-spotted gourami Fish (Trichogaster trichopterus)
Subject Areas :
Mohammadreza Pouravaz
1
(
Faculty of pharmacy and pharmaceutical science, Tehran Medical science, Islamic Azad university, Tehran, Iran
)
طاهره ناجی
2
(
گروه علوم پایه ،دانشکده داروسازی و علوم دارویی،علوم پزشکی تهران،دانشگاه آزاد اسلامی،تهران،ایران.
)
Homayon Hosseinzadeh sahafi
3
(
Iranian Fisheries Science Research Institute, Agricultural research, education and Promotion organization, Tehran, Iran.
)
Received: 2022-05-10
Accepted : 2022-08-07
Published : 2023-07-23
Keywords:
liver enzymes,
liver tissue,
Trichogaster trichopterus,
melatonin,
citalopram,
Abstract :
Background & Aims: Most of the various drugs that are used to treat various diseases are metabolized in the liver. The purpose of this study is to investigate the effect of melatonin and selective serotonin reuptake inhibitor drug citalopram on liver tissue ultrastructure and liver enzymes in adult female Trichogaster.
Materials & Methods: For this purpose, 120 pieces of Trichogaster with an average weight of 4.23 ± 0.70 g divided into eight groups of 15, which included the control groups, solvent intact, three groups which received citalopram with a dose of 5, 10 and 20 mg/kg and three treatment groups receiving melatonin with doses of 10, 50, and 100 mg/kg. A dose of 0.02 ml of the drug was injected intramuscularly between the dorsal fin and the lateral line every other day for 10 times, over a period of 20 days. Then, the fish were euthanized and dissected.
Results: The results showed that melatonin and citalopram had a significant effect on the level of all liver enzymes compared to the control groups (P<0.05). The highest levels of ALT, AST and ALP were measured after the injection of 20 mg/kg citalopram (P<0.05). In fish treated with the highest concentration of melatonin and all concentrations of citalopram, dissociation between hepatocytes and expansion of sinusoids occurred. Fat vacuoles were formed in high concentrations of melatonin and citalopram.
Conclusion: Therefore, melatonin at a concentration of 100 mg/kg and citalopram at a concentration higher than 5 mg/kg have a negative effect on the ultrastructure of liver tissue and liver enzymes.
References:
Abdel-Razaq W, Kendall DA, Bates TE. 2011. The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochemicalresearch.36:327-338.
Abdi S, Abbasinazari M, Ataei S, Khanzadeh-Moghaddam N, Keshvari N. 2021. Benefits and Risks of Melatonin in Hepatic and Pancreatic Disorders; A Review of Clinical Evidences. Iranian Journal of Pharmaceutical Research: IJPR. 20(3):102- 109.
Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX, Reiter RJ. 2014. Extra pineal melatonin: sources, regulation, and potential functions. Cellular and molecular life sciences. 71: 2997-3025.
Adebayo JO, Yakubu MT, Egwim EC, Owoyele VB, Enaibe BU. 2003. Effect of ethanolic extract of Khaya senegalensis on some biochemical parameters of rat kidney. Journal of Ethnopharmacology. 88(1):69-72.
Ahmadian E, Eftekhari A, Fard JK, Babaei H, Nayebi AM, Mohammad nejad D, Eghbal MA. 2017. In vitro and in vivo evaluation of the mechanisms of citalopram-induced hepatotoxicity. Archives of pharmacal research. 40:1296-1313.
Ahmadian E, Jafari S, Yari Khosroushahi A. 2015. Role of angiotensin II in stem cell therapy of cardiac disease. Journal of the Renin-Angiotensin-Aldosterone System. 16(4):702-711.
Bahrami M, Cheraghpour M, Jafarirad S, Alavinejad P, Asadi F, Hekmatdoost A, Mohammadi M, Yari Z. 2020. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. Complementary therapies in medicine. 52:1-10.
Bali İ, Bilir B, Emir S, Turan F, Yılmaz A, Gökkuş T, Aydın M. 2016. The effects of melatonin on liver functions in arsenic-induced liver damage. Turkish Journal of Surgery/Ulusal Cerrahi Dergisi. 32(4):233-237.
BayIr H, Kagan VE. 2008. Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis–there is nothing more practical than a good theory. Critical care. 12(1):1-11.
Boya P, Kroemer G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene. 27(50):6434-51.
Eftekhari A, Azarmi Y, Parvizpur A, Eghbal MA. 2016. Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes. Xenobiotica. 46(4):369-78.
H Park S, Ishino R. 2013. Liver injury associated with antidepressants. Current drug safety. 8(3):207-23.
Hu C, Zhao L, Tao J, Li L. 2019. Protective role of melatonin in early‐stage and end‐stage liver cirrhosis. Journal of cellular and molecular medicine. 23(11):7151-62.
Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. 2002. Mechanisms of hepatotoxicity. Toxicological sciences. 65(2):166-76.
Jaeschke H, McGill MR, Ramachandran A. 2012. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug metabolism reviews. 44(1):88-106.
Karimi Mohammadi M, Vaezi G.M, Zarei H. 2014. Investigating the effect of oral melatonin on SGOT and SGPT levels of liver enzymes in healthy and diabetic rats treated with streptozotocin. Congress of Physiology and Pharmacology of Iran.
Licata A. 2016. Adverse drug reactions and organ damage: the liver. European journal of internal medicine. 28:9-16.
Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J. 2017. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA psychiatry. 74(10):1011-20.
Lopez-Torres E, Lucena MI, Seoane J, Verge C, Andrade RJ. 2004. Hepatotoxicity related to citalopram. American Journal of Psychiatry. 161(5):923-a.
Luzio JP, Pryor PR, Bright NA. 2007. Lysosomes: fusion and function. Nature reviews Molecular cell biology. 8(8):622-632.
Manchester LC, Coto‐Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX, Reiter RJ. 2015. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. Journal of pineal research. 59(4):403-19.
Mohammadi Z, Azarnia M, Mirabolghasemi G, Shiravi A, Mohammadi Z. 2013. Histological changes in the liver of fetuses of pregnant rats following citalopram administration. Indian Journal of Pharmacology. 45(5):517.
Muradpour R, Shokri M, Talebpour Amiri F, Elahwardi A. 2018. Melatonin reduces liver damage caused by mobile phone radiofrequency waves in an experimental mouse model. Journal of paramedical sciences and military health. 12(4):1-8.
Pakravan H, Ahmadian M, Fani A, Aghaee D, Brumanad S, Pakzad B. 2017. The effects of melatonin in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Advanced biomedical research. 6: 1-5.
Pourahmad J, Eskandari MR, Kaghazi A, Shaki F, Shahraki J, Fard JK. 2012. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis. Toxicology in Vitro. 26(4): 545-551.
Ren W, Liu G, Chen S, Yin J, Wang J, Tan B, Wu G, Bazer FW, Peng Y, Li T, Reiter RJ. 2017. Melatonin signaling in T cells: Functions and applications. Journal of pineal research. 62(3): 1-15.
Roberts JR. 2022. InFocus: Melatonin Overdoses Rising Among Children. Emergency Medicine News. 44(8):8-9.
Sadeghi A, Abbasinazari M, Aghdaei HA, Abdi S, Hatami B, Rasoolinezhad M, Jamshidzadeh S, Saadati S. 2019. Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangio pancreatography pancreatitis? A randomized double-blind controlled trial. European Journal of Gastroenterology & Hepatology. 31(11):1350-1355.
Sangkuhl K, Klein TE, Altman RB. 2011. Pharm GKB summary: citalopram pharmacokinetics pathway. Pharmacogenetics and genomics. 21(11):769-772.
Schuster D, Laggner C, Langer T. 2005. Why drugs fail-a study on side effects in new chemical entities. Current pharmaceutical design. 11(27):3545-359.
Sharma S, Rana SV. 2013. Melatonin improves liver function in benzene-treated rats. Arhiv za higijenu rada i toksikologiju. 64(2):219-226.
Sun H, Huang FF, Qu S. 2015. Melatonin: a potential intervention for hepatic steatosis. Lipids in Health and Disease. 14:1-6.
Voican CS, Corruble E, Naveau S, Perlemuter G. 2014. Antidepressant-induced liver injury: a review for clinicians. American Journal of Psychiatry. 171(4):404-415.
Xia Z, Lundgren B, Bergstrand A, DePierre JW, Nässberger L. 1999. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-XL. Biochemical pharmacology. 57(10):1199-1208.
Yang X, He C, Zhu L, Zhao W, Li S, Xia C, Xu C. 2019. Comparative analysis of regulatory role of Notch signaling pathway in 8 types liver cell during liver regeneration. Biochemical genetics. 57:1-9.
Zhang JJ, Meng X, Li Y, Zhou Y, Xu DP, Li S, Li HB. 2017. Effects of melatonin on liver injuries and diseases. International Journal of Molecular Sciences. 18(4):1-27.
_||_
